Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Luster

Showing results (11-20 of 181) with videos related to

Pageof 19
Sort By:
Frontiers in Nuclear Medicine|October 2, 2024
Shared Decision Making for Radioiodine Therapy and the Actual Pattern of Care in Intermediate-Risk Differentiated Thyroid CarcinomaFriederike Eilsberger, Markus Luster, Christoph Reiners
Endocrine Connections|October 28, 2020
Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative reviewSalman Razvi, Sanaa Mrabeti, Markus Luster
Deutsche Medizinische Wochenschrift (1946)|July 16, 2024
[Nuclear medicine approaches in the diagnosis and treatment of neuroendocrine neoplasms]Maximilian Kaletsch, Andreas Pfestroff, Markus Luster
Chirurgie (Heidelberg, Germany)|January 29, 2026
[Novel imaging techniques for the differential diagnosis of adrenal tumors, pheochromocytomas and paragangliomas]Friederike Eilsberger, Kerstin Michalski, Markus Luster
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2008
Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspectiveMarkus Luster, Martin Schlumberger, Furio Pacini
Best Practice & Research. Clinical Endocrinology & Metabolism|December 2, 2008
Radio-iodine therapy in differentiated thyroid cancer: indications and proceduresChristoph Reiners, Markus Dietlein, Markus Luster
Endocrine-Related Cancer|May 8, 2010
Dosimetry and thyroid cancer: the individual dosage of radioiodineMichael Lassmann, Christoph Reiners, Markus Luster
Nuklearmedizin. Nuclear Medicine|February 3, 2021
[Nursing in Nuclear medicine - decisive factor for future Theranostics]Marcel Wieditz, Markus Essler, Markus Luster
Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
Radioactive iodine (RAI) therapy for metastatic differentiated thyroid cancerFrederik A Verburg, Heribert Hänscheid, Markus Luster
Nature Reviews. Endocrinology|July 2, 2014
Differentiated thyroid cancer-personalized therapies to prevent overtreatmentMarkus Luster, Theresia Weber, Frederik A Verburg
Pageof 19

Showing results (11-20 of 181) with videos related to

Sort By:
Pageof 19
Frontiers in Nuclear Medicine|October 2, 2024
Shared Decision Making for Radioiodine Therapy and the Actual Pattern of Care in Intermediate-Risk Differentiated Thyroid CarcinomaFriederike Eilsberger, Markus Luster, Christoph Reiners
Endocrine Connections|October 28, 2020
Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative reviewSalman Razvi, Sanaa Mrabeti, Markus Luster
Deutsche Medizinische Wochenschrift (1946)|July 16, 2024
[Nuclear medicine approaches in the diagnosis and treatment of neuroendocrine neoplasms]Maximilian Kaletsch, Andreas Pfestroff, Markus Luster
Chirurgie (Heidelberg, Germany)|January 29, 2026
[Novel imaging techniques for the differential diagnosis of adrenal tumors, pheochromocytomas and paragangliomas]Friederike Eilsberger, Kerstin Michalski, Markus Luster
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2008
Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspectiveMarkus Luster, Martin Schlumberger, Furio Pacini
Best Practice & Research. Clinical Endocrinology & Metabolism|December 2, 2008
Radio-iodine therapy in differentiated thyroid cancer: indications and proceduresChristoph Reiners, Markus Dietlein, Markus Luster
Endocrine-Related Cancer|May 8, 2010
Dosimetry and thyroid cancer: the individual dosage of radioiodineMichael Lassmann, Christoph Reiners, Markus Luster
Nuklearmedizin. Nuclear Medicine|February 3, 2021
[Nursing in Nuclear medicine - decisive factor for future Theranostics]Marcel Wieditz, Markus Essler, Markus Luster
Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
Radioactive iodine (RAI) therapy for metastatic differentiated thyroid cancerFrederik A Verburg, Heribert Hänscheid, Markus Luster
Nature Reviews. Endocrinology|July 2, 2014
Differentiated thyroid cancer-personalized therapies to prevent overtreatmentMarkus Luster, Theresia Weber, Frederik A Verburg
Pageof 19